Wei-ping M. Zhou
225 Changhai Road
Shanghai, 200438, China
Shanghai, 200438, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Retraction: Rpb3 promotes hepatocellular carcinoma through its N-terminus.
Journal: Oncotarget
Published: January 20, 2025
Preoperative prediction of textbook outcome in intrahepatic cholangiocarcinoma by interpretable machine learning: A multicenter cohort study.
Journal: World journal of gastroenterology
Published: August 30, 2024
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target.
Journal: Hepatology communications
Published: March 19, 2024
IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway.
Journal: Cell death discovery
Published: January 17, 2024
Nomogram for prediction of severe postoperative complications in elective hepato-pancreato-biliary surgery after COVID-19 breakthrough infection: A large multicenter study.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: January 10, 2024
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
Journal: BMC cancer
Published: September 21, 2023
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma.
Journal: Hepatology international
Published: July 10, 2023
Gasless single-incision laparoscopic hepatectomy.
Journal: Asian journal of surgery
Published: June 22, 2023
Retraction Note: Downregulation of miR-196-5p induced by hypoxia drives tumorigenesis and metastasis in hepatocellular carcinoma.
Journal: Discover oncology
Published: April 24, 2023
Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study.
Journal: Frontiers in immunology
Published: April 01, 2023
Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation.
Journal: Experimental & molecular medicine
Published: January 12, 2023
Last Updated: 09/26/2026